Company 1 identity field
Location
Boston, MA
SEC filing record 1 source field
Fiscal year end
31 December
Aura Biosciences, Inc. has filed 346 SEC EDGAR filings since 21 Sep 2010

SEC filing history

Showing 276-300 of 346 matching filings.

Per page
25
Current page
12
SC 13G/A File 005-92997

AURA BIOSCIENCES, INC.

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92997

FORM SC 13G

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92997

SC 13G/A

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92997

SC 13G

Filing date
26 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92997

SC 13G

Filing date
12 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92997

SC 13G

Filing date
12 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92997

SC 13D

Filing date
10 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92997

SC 13G

Filing date
10 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Nov 2021
Reporting date
02 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92997

AURA BIOSCIENCES, INC.

Filing date
04 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Nov 2021
Reporting date
02 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Nov 2021
Reporting date
02 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Nov 2021
Reporting date
02 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40971

8-K

Filing date
02 Nov 2021
Reporting date
02 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-260156

424B4

Filing date
01 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Oct 2021
Reporting date
28 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Oct 2021
Reporting date
28 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Oct 2021
Reporting date
28 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Oct 2021
Reporting date
28 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Oct 2021
Reporting date
28 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Oct 2021
Reporting date
28 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Oct 2021
Reporting date
28 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Oct 2021
Reporting date
28 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .